Literature DB >> 30277289

High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis.

Keiichi Fujiwara1, Ryuzo Abe2, Shin Yasui1, Osamu Yokosuka1, Naoya Kato1, Shigeto Oda2.   

Abstract

AIM: An artificial liver support (ALS) system sustaining patients with acute liver failure (ALF) in good condition until recovery of the native liver or performance of liver transplantation (LT), is essential for the improvement of the poor prognosis of ALF despite the lack of survival benefit. We aimed to investigate the efficacy of various ALS systems for fulminant hepatitis (FH) carried out in our liver unit so far, focusing on the restoration of consciousness from hepatic encephalopathy.
METHODS: One hundred and ten consecutive adult Japanese patients with FH admitted to Chiba University Hospital (Chiba, Japan) between 1988 and 2016 who received ALS were analyzed.
RESULTS: Recovery rate of consciousness improved with the increased dialysate flow rate and filtrate rate: 37.5% by plasma exchange (PE), 51.9% by PE + continuous hemodiafiltration (CHDF), 57.7% by slow PE (sPE) + high-flow CHDF (HFCHDF) (QD  = 300 mL/min), 88.6% by HFCHDF (QD  = 500 mL/min) (+ sPE), and 92.9% by on-line HDF (OLHDF) (+ sPE). All patients except one, who could not be fully treated because of circulatory failure, recovered consciousness by OLHDF, including those whose liver function were completely abolished. Superiority of HFCHDF (QD  = 500 mL/min) and OLHDF was also shown in patients who died without LT or received LT.
CONCLUSIONS: More effective ALS should be recognized considering the extremely high recovery rate of consciousness. In particular, OLHDF with predilution reduces the cost of substitution fluid by supplying an unlimited amount of dialysate as substitution fluid prepared using an on-line system, and simplifies the procedure for the management.
© 2018 The Japan Society of Hepatology.

Entities:  

Keywords:  acute liver failure; artificial liver support; fulminant hepatitis; hepatic encephalopathy; on-line hemodiafiltration

Year:  2018        PMID: 30277289     DOI: 10.1111/hepr.13255

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  5 in total

Review 1.  Changes in acute blood purification therapy in critical care: republication of the article published in the Japanese Journal of Artificial Organs.

Authors:  Taka-Aki Nakada; Shigeto Oda; Ryuzo Abe; Noriyuki Hattori
Journal:  J Artif Organs       Date:  2019-06-24       Impact factor: 1.731

Review 2.  End-stage liver failure: filling the treatment gap at the intensive care unit.

Authors:  Robert A F M Chamuleau; Ruurdtje Hoekstra
Journal:  J Artif Organs       Date:  2019-09-18       Impact factor: 1.731

3.  Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.

Authors:  Koji Imoto; Masatake Tanaka; Takeshi Goya; Tomomi Aoyagi; Motoi Takahashi; Miho Kurokawa; Shigeki Tashiro; Masaki Kato; Motoyuki Kohjima; Yoshihiro Ogawa
Journal:  BMC Gastroenterol       Date:  2022-03-28       Impact factor: 3.067

4.  Fulminant Hepatitis due to de novo Hepatitis B after Cord Blood Transplantation Rescued by Medical Treatment.

Authors:  Tomoya Sano; Norio Akuta; Yoshiyuki Suzuki; Kayoko Kasuya; Shunichiro Fujiyama; Yusuke Kawamura; Hitomi Sezaki; Tetsuya Hosaka; Satoshi Saitoh; Masahiro Kobayashi; Fumitaka Suzuki; Mariko Kobayashi; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

5.  Early identification using the referral system prolonged the time to onset for hepatic encephalopathy after diagnosing severe acute liver injury.

Authors:  Keisuke Kakisaka; Yuji Suzuki; Hiroaki Abe; Takuya Watanabe; Kenji Yusa; Hiroki Sato; Yasuhiro Takikawa
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.